Mesakol for treating diverticula disease
Purpose: to assess effectiveness and tolerance to preparation Mesakol (mesalazin) for treating patients with clinically marked diverticula disease of the colon. To verify diverticula disease of the colon and its complications 20 patients have been examined with modern diagnostic tools (irrigoscopy, colonoscopy, ultrasound visualization, electromyography, evaluation of qualitative and quantitative indexes of intestinal flora metabolites). Results: Studies performed have shown a positive effect of 30-day course of Mesakol therapy in patients with clinically marked diverticula disease. Mesakol prescribed in the dosage 1.2 gr per day has led to a complete control of abdominal symptoms in 70% of patients. Thus, the discussed disease has been transformed into a symptom free form in the majority of patients. It means that preparation Mesakol has good curative and prophylactic effects in uncomplicated forms of diverticula disease of the colon.